感染症治療薬の世界市場（～2026年）

• 英文タイトル：Global Infectious Disease Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12366 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（薬剤、ワクチン）市場規模、用途別（HIV/AIDS、インフルエンザ、肝炎、マラリア、結核、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別感染症治療薬の競争状況、市場シェア ・世界の感染症治療薬市場：種類別市場規模 2015年-2020年（薬剤、ワクチン） ・世界の感染症治療薬市場：種類別市場規模予測 2021年-2026年（薬剤、ワクチン） ・世界の感染症治療薬市場：用途別市場規模 2015年-2020年（HIV/AIDS、インフルエンザ、肝炎、マラリア、結核、その他） ・世界の感染症治療薬市場：用途別市場規模予測 2021年-2026年（HIV/AIDS、インフルエンザ、肝炎、マラリア、結核、その他） ・北米の感染症治療薬市場分析：米国、カナダ ・ヨーロッパの感染症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの感染症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の感染症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの感染症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis AG、Gilead、GlaxoSmithKline plc、Janssen Pharmaceutical Inc.、F. Hoffmann-La Roche Ltd.、BioCryst Pharmaceuticals Inc.、Merck & Co. Inc.、Boehringer Ingelheim GmbH ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.
Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.

Market Analysis and Insights: Global Infectious Disease Therapeutics Market
The global Infectious Disease Therapeutics market size is projected to reach US$ 47580 million by 2026, from US$ 45730 million in 2020, at a CAGR of 3.7%% during 2021-2026.

Global Infectious Disease Therapeutics Scope and Market Size
Infectious Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH

Market segment by Type, the product can be split into
Drugs
Vaccines
Market segment by Application, split into
HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Infectious Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs
1.4.3 Vaccines
1.5 Market by Application
1.5.1 Global Infectious Disease Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 HIV/AIDS
1.5.3 Influenza
1.5.4 Hepatitis
1.5.5 Malaria
1.5.6 Tuberculosis
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Infectious Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Infectious Disease Therapeutics Growth Trends by Regions
2.2.1 Infectious Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infectious Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Infectious Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infectious Disease Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Infectious Disease Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Therapeutics Players by Market Size
3.1.1 Global Top Infectious Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Therapeutics Market Concentration Ratio
3.2.1 Global Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Therapeutics Revenue in 2019
3.3 Infectious Disease Therapeutics Key Players Head office and Area Served
3.4 Key Players Infectious Disease Therapeutics Product Solution and Service
3.5 Date of Enter into Infectious Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Infectious Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Infectious Disease Therapeutics Market Size by Application (2015-2020)
5.2 Global Infectious Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Infectious Disease Therapeutics Market Size (2015-2020)
6.2 Infectious Disease Therapeutics Key Players in North America (2019-2020)
6.3 North America Infectious Disease Therapeutics Market Size by Type (2015-2020)
6.4 North America Infectious Disease Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Infectious Disease Therapeutics Market Size (2015-2020)
7.2 Infectious Disease Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Therapeutics Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Infectious Disease Therapeutics Market Size (2015-2020)
8.2 Infectious Disease Therapeutics Key Players in China (2019-2020)
8.3 China Infectious Disease Therapeutics Market Size by Type (2015-2020)
8.4 China Infectious Disease Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Infectious Disease Therapeutics Market Size (2015-2020)
9.2 Infectious Disease Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Therapeutics Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Infectious Disease Therapeutics Market Size (2015-2020)
10.2 Infectious Disease Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Infectious Disease Therapeutics Market Size (2015-2020)
11.2 Infectious Disease Therapeutics Key Players in India (2019-2020)
11.3 India Infectious Disease Therapeutics Market Size by Type (2015-2020)
11.4 India Infectious Disease Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Infectious Disease Therapeutics Market Size (2015-2020)
12.2 Infectious Disease Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis AG
13.1.1 Novartis AG Company Details
13.1.2 Novartis AG Business Overview
13.1.3 Novartis AG Infectious Disease Therapeutics Introduction
13.1.4 Novartis AG Revenue in Infectious Disease Therapeutics Business (2015-2020))
13.1.5 Novartis AG Recent Development
13.2 Gilead
13.2.1 Gilead Company Details
13.2.2 Gilead Business Overview
13.2.3 Gilead Infectious Disease Therapeutics Introduction
13.2.4 Gilead Revenue in Infectious Disease Therapeutics Business (2015-2020)
13.2.5 Gilead Recent Development
13.3 GlaxoSmithKline plc
13.3.1 GlaxoSmithKline plc Company Details
13.3.2 GlaxoSmithKline plc Business Overview
13.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Introduction
13.3.4 GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2015-2020)
13.3.5 GlaxoSmithKline plc Recent Development
13.4 Janssen Pharmaceutical Inc.
13.4.1 Janssen Pharmaceutical Inc. Company Details
13.4.2 Janssen Pharmaceutical Inc. Business Overview
13.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Introduction
13.4.4 Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020)
13.4.5 Janssen Pharmaceutical Inc. Recent Development
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 F. Hoffmann-La Roche Ltd. Company Details
13.5.2 F. Hoffmann-La Roche Ltd. Business Overview
13.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Introduction
13.5.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Ltd. Recent Development
13.6 BioCryst Pharmaceuticals Inc.
13.6.1 BioCryst Pharmaceuticals Inc. Company Details
13.6.2 BioCryst Pharmaceuticals Inc. Business Overview
13.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Introduction
13.6.4 BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020)
13.6.5 BioCryst Pharmaceuticals Inc. Recent Development
13.7 Merck & Co. Inc.
13.7.1 Merck & Co. Inc. Company Details
13.7.2 Merck & Co. Inc. Business Overview
13.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Introduction
13.7.4 Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020)
13.7.5 Merck & Co. Inc. Recent Development
13.8 Boehringer Ingelheim GmbH
13.8.1 Boehringer Ingelheim GmbH Company Details
13.8.2 Boehringer Ingelheim GmbH Business Overview
13.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Introduction
13.8.4 Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2015-2020)
13.8.5 Boehringer Ingelheim GmbH Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Infectious Disease Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Disease Therapeutics Revenue
Table 3. Ranking of Global Top Infectious Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Vaccines
Table 7. Global Infectious Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Infectious Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Infectious Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Infectious Disease Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Infectious Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Infectious Disease Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Infectious Disease Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Infectious Disease Therapeutics Players
Table 18. Global Infectious Disease Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Infectious Disease Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Therapeutics as of 2019)
Table 21. Global Infectious Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infectious Disease Therapeutics Product Solution and Service
Table 24. Date of Enter into Infectious Disease Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Infectious Disease Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Infectious Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Infectious Disease Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Infectious Disease Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Infectious Disease Therapeutics Market Share (2019-2020)
Table 34. North America Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 36. North America Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Infectious Disease Therapeutics Market Share (2019-2020)
Table 40. Europe Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Infectious Disease Therapeutics Market Share (2019-2020)
Table 46. China Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 48. China Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Infectious Disease Therapeutics Market Share (2019-2020)
Table 52. Japan Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Infectious Disease Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Infectious Disease Therapeutics Market Share (2019-2020)
Table 64. India Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 66. India Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Infectious Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Infectious Disease Therapeutics Market Share (2019-2020)
Table 70. Central & South America Infectious Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Infectious Disease Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Infectious Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Infectious Disease Therapeutics Market Share by Application (2015-2020)
Table 74. Novartis AG Company Details
Table 75. Novartis AG Business Overview
Table 76. Novartis AG Product
Table 77. Novartis AG Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 78. Novartis AG Recent Development
Table 79. Gilead Company Details
Table 80. Gilead Business Overview
Table 81. Gilead Product
Table 82. Gilead Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 83. Gilead Recent Development
Table 84. GlaxoSmithKline plc Company Details
Table 85. GlaxoSmithKline plc Business Overview
Table 86. GlaxoSmithKline plc Product
Table 87. GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline plc Recent Development
Table 89. Janssen Pharmaceutical Inc. Company Details
Table 90. Janssen Pharmaceutical Inc. Business Overview
Table 91. Janssen Pharmaceutical Inc. Product
Table 92. Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 93. Janssen Pharmaceutical Inc. Recent Development
Table 94. F. Hoffmann-La Roche Ltd. Company Details
Table 95. F. Hoffmann-La Roche Ltd. Business Overview
Table 96. F. Hoffmann-La Roche Ltd. Product
Table 97. F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 98. F. Hoffmann-La Roche Ltd. Recent Development
Table 99. BioCryst Pharmaceuticals Inc. Company Details
Table 100. BioCryst Pharmaceuticals Inc. Business Overview
Table 101. BioCryst Pharmaceuticals Inc. Product
Table 102. BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 103. BioCryst Pharmaceuticals Inc. Recent Development
Table 104. Merck & Co. Inc. Company Details
Table 105. Merck & Co. Inc. Business Overview
Table 106. Merck & Co. Inc. Product
Table 107. Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 108. Merck & Co. Inc. Recent Development
Table 109. Boehringer Ingelheim GmbH Business Overview
Table 110. Boehringer Ingelheim GmbH Product
Table 111. Boehringer Ingelheim GmbH Company Details
Table 112. Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2015-2020) (Million US$)
Table 113. Boehringer Ingelheim GmbH Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Vaccines Features
Figure 4. Global Infectious Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. HIV/AIDS Case Studies
Figure 6. Influenza Case Studies
Figure 7. Hepatitis Case Studies
Figure 8. Malaria Case Studies
Figure 9. Tuberculosis Case Studies
Figure 10. Others Case Studies
Figure 11. Infectious Disease Therapeutics Report Years Considered
Figure 12. Global Infectious Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Infectious Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Infectious Disease Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Infectious Disease Therapeutics Market Share by Players in 2019
Figure 17. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Infectious Disease Therapeutics Revenue in 2019
Figure 19. North America Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Infectious Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

---